The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reckitt Benckiser Q1 sales jump, FY outlook lifted

Thu, 30th Apr 2020 07:36

(Sharecast News) - Consumer goods company Reckitt Benckiser lifted its full-year outlook on Thursday and reported a jump in first-quarter sales as demand for its products was boosted by the coronavirus pandemic.
In the three months to the end of March, total sales rose 12.3% to ?3.5bn, with like-for-like sales up 13.3%. Reckitt said growth was led by strong demand for many of its hygiene and health products, in particular Dettol, Lysol, Mucinex, Nurofen and VMS.

Reckitt said its 2020 performance is now expected to be ahead of original expectations, although the outlook for the balance of 2020 remains uncertain, with significant Covid-19 challenges across its markets.

Chief executive officer Laxman Narasimhan said: "We have seen strong consumer demand, particularly in March and April but the split between defensive buying and higher levels of underlying consumption is unclear.

"At this stage, it is uncertain how quickly this will change in the months ahead. Improved penetration and usage, particularly for products like Dettol and Lysol, may well sustain, although we will likely see some unwinding of 'pantry load' as we work our way through the crisis. The near-term operational challenges to meet additional demand and handle lockdown conditions, with the associated costs, are also likely to continue for some time."

At 1315 BST, the shares were up 4.3% at 6,674p.

Russ Mould, investment director at AJ Bell, said: "Reckitt Benckiser has demonstrated that not everyone is suffering equally in the coronavirus crisis. The consumer goods giant lifting outlook guidance feels like a dose of vitamins to a market facing a wave of profit warnings, dividend cuts and fundraisings.

"Reckitt's slant towards health and hygiene chimes perfectly with the need to look after ourselves and the reality that cleanliness is now less of an aspiration and more of a necessity. It is little surprise to see brands like Dettol, Lysol, Mucinex and Nurofen in demand.

"The business also seems to have passed the supply chain test in the face of exceptional demand that saw a substantial increase in sales in a very short period. The company is also doing its bit in the effort to tackle the pandemic by putting 1% of profit into a support fund, thereby ticking the good corporate citizen box.

"Although sales were lifted by stockpiling as the crisis took hold, it seems likely that some of the changes to consumer behaviour in the wake of the pandemic will be lasting. This could provide some extra pep to the recovery plan being delivered by CEO Laxman Narasimhan."

More News
29 Jul 2020 13:29

Wednesday broker round-up

(Sharecast News) - Sanne: RBC Capital Markets reiterates sector performer with a target price of 600.0p.

Read more
29 Jul 2020 09:47

UK BROKER RATINGS SUMMARY: Berenberg Raises Carnival To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises Carnival To Hold From Sell

Read more
28 Jul 2020 17:01

LONDON MARKET CLOSE: FTSE 100 Ends Higher Thanks To Housebuilders

LONDON MARKET CLOSE: FTSE 100 Ends Higher Thanks To Housebuilders

Read more
28 Jul 2020 13:36

Reckitt seeks to cash in on cleaning brands with partnerships

By Siddharth CavaleJuly 28 (Reuters) - Exploiting the strength of Lysol and Dettol brands, Reckitt Benckiser is seeking bespoke supply and sanitation deals with travel companies and hotels as the coronavirus crisis makes hygiene a high priority.Br...

Read more
28 Jul 2020 11:04

UK TOP NEWS SUMMARY: Reckitt Gets Virus Boost For Cleaning Products

UK TOP NEWS SUMMARY: Reckitt Gets Virus Boost For Cleaning Products

Read more
28 Jul 2020 09:34

UPDATE 2-Defensives buoy UK stocks ahead of Fed outcome, U.S. stimulus decision

(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Greggs shares slip despite jump in sales* Reckitt Benckiser, Card Factory rise after results* BHP, Rio biggest drag on FTSE 100* FTSE 100 up 0.4%, FTSE 250 adds 0.7% (Updates...

Read more
28 Jul 2020 08:41

LONDON MARKET OPEN: Stocks Start Higher As US Stimulus, Fed Meet Eyed

LONDON MARKET OPEN: Stocks Start Higher As US Stimulus, Fed Meet Eyed

Read more
28 Jul 2020 08:38

TOP NEWS: Reckitt Benckiser Interim Revenue Rises On Cleaning Products

TOP NEWS: Reckitt Benckiser Interim Revenue Rises On Cleaning Products

Read more
28 Jul 2020 08:02

LONDON BRIEFING: Reckitt Benckiser Rides Covid-19 "Tailwinds"

LONDON BRIEFING: Reckitt Benckiser Rides Covid-19 "Tailwinds"

Read more
28 Jul 2020 07:45

LONDON MARKET PRE-OPEN: Reckitt Hails Strong Half As Dettol Gets Boost

LONDON MARKET PRE-OPEN: Reckitt Hails Strong Half As Dettol Gets Boost

Read more
28 Jul 2020 07:34

UPDATE 2-Increased hygiene practices boost Reckitt Benckiser's first half

* Raises 2020 sales view to high single-digits* Lysol, Dettol are top performing brands* Shares down 1.6% after rising 25% this year (Adds details on brand sales, CEO quote, shares)By Siddharth CavaleJuly 28 (Reuters) - British consumer goods maker ...

Read more
28 Jul 2020 07:26

Cleaning product demand boosts Reckitt Benckiser H1

(Sharecast News) - Consumer goods giant Reckitt Benckiser reported a jump in first-half net revenue and profit on Tuesday thanks to a strong performance from its health and hygiene businesses as the Covid-19 pandemic boosted demand for cleaning and pain relief products.

Read more
27 Jul 2020 17:00

Delta teams up with Lysol to innovate on travel hygiene

CHICAGO, July 27 (Reuters) - Delta Air Lines said on Monday it is teaming up with Reckitt Benckiser Group Plc, the makers of Lysol, to research and develop new disinfecting solutions for high-traffic areas in airports and onboard, with a first fo...

Read more
24 Jul 2020 16:05

UPDATE 2-Indivior to pay $600 million to settle U.S. opioid treatment marketing claims

(Adds details from Justice Department)By Nate RaymondJuly 24 (Reuters) - Indivior Plc has agreed to pay $600 million and have a subsidiary plead guilty to a felony charge to resolve U.S. allegations that it engaged in an illegal scheme to boost pr...

Read more
24 Jul 2020 16:05

UPDATE 1-Indivior to resolve U.S. opioid treatment marketing claims for $600 million

(Adds further details on settlement, background on case)By Nate RaymondJuly 24 (Reuters) - Indivior Plc on Friday said it had agreed to pay $600 million and have a subsidiary plead guilty to a criminal charge to resolve U.S. allegations that it en...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.